STSN (Stemsation International) Total Liabilities: $0.53 Mil (As of Sep. 2011)


What is Stemsation International Total Liabilities?

Stemsation International STSN +60.53% Total Liabilities is $0.53 Mil as of Sep. 2011.

Stemsation International's Total Liabilities for the quarter that ended in Sep. 2011 was $0.53 Mil.

Stemsation International's quarterly Total Liabilities declined from Mar. 2011 ($0.49 Mil) to Jun. 2011 ($0.46 Mil) but then increased from Jun. 2011 ($0.46 Mil) to Sep. 2011 ($0.53 Mil).

Stemsation International's annual Total Liabilities increased from Dec. 2008 ($0.01 Mil) to Dec. 2009 ($0.02 Mil) and increased from Dec. 2009 ($0.02 Mil) to Dec. 2010 ($0.31 Mil).

Stemsation International Total Liabilities Historical Data

* Premium members only.

The historical data trend for Stemsation International's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stemsation International Total Liabilities Chart

Stemsation International Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
Total Liabilities
0.11 0.16 0.01 0.02 0.31

Stemsation International Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.31 0.49 0.46 0.53

Stemsation International Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Stemsation International's Total Liabilities for the fiscal year that ended in Dec. 2010 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.007+(0.3+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.31

Total Liabilities=Total Assets (A: Dec. 2010 )-Total Equity (A: Dec. 2010 )
=0.326-0.019
=0.31

Stemsation International's Total Liabilities for the quarter that ended in Sep. 2011 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.184+(0.345+-0.00099999999999995
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.53

Total Liabilities=Total Assets (Q: Sep. 2011 )-Total Equity (Q: Sep. 2011 )
=0.243--0.285
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.53 Mil mean?
Stemsation International (STSN) has a Total Liabilities of $0.53 Mil as of Sep. 2011. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Stemsation International and its competitors.
Is Stemsation International's Total Liabilities too high?
Stemsation International's current Total Liabilities is $0.53 Mil.
How does Stemsation International's Total Liabilities compare to MAMP and LODE?
Stemsation International's Total Liabilities of $0.53 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Stemsation International and its competitors. Stemsation International's current Total Liabilities is $0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stemsation International stock overvalued right now?
Stemsation International (STSN) has a current Total Liabilities of $0.53 Mil. The current Total Liabilities is $0.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Stemsation International (STSN), the current Total Liabilities is $0.53 Mil as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stemsation International Business Description

Address 9555 Bergamot Street, Lake Worth, FL, USA, 33467
Stemsation International Inc is developing a line of canned, flavored oxygen products to be sold business-to-business (B2B) and direct to consumers (DTC). These products will be distributed to the beverage industry, as well as to restaurants and bars. It is also developing R&D and manufacturing relationships for additional products and services.